Completeness of histopathology reporting of melanoma in a high-incidence geographical region

Dermatology

Volumn 218, Issue 1, 2009, Pages 7-14

  Thompson, B ^a,f   Austin, R ^a   Coory, M ^b   Aitken, J F ^a   Walpole, E ^c   Francis, G ^d   Fritschi, L ^e  

^a Viertel Centre for Research in Cancer Control   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d QUEENSLAND HEALTH   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

Author keywords

Clinical practice guidelines; Histopathology report; Laboratory melanoma reporting volume; Melanoma

Indexed keywords

ARTICLE; AUSTRALIA; CANCER REGRESSION; CELL TYPE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PRACTICE; GROWTH CURVE; HISTOPATHOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; MELANOMA; MITOSIS RATE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUMOR VOLUME; ULCER;

EID: 58149090396     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000161116     Document Type: Article

References (27)

1. Gloster HM Jr, Brodland DG: The epidemiology of skin cancer. Dermatol Surg 1996;22:217-226.
2. The Australian Cancer Network: Clinical Practice Guidelines for the Management of Cutaneous Melanoma. Canberra, National Health and Medical Research Council, 1999.
3. Metcalf JS: Melanoma: criteria for histological diagnosis and its reporting. Semin Oncol 1996;23:688-692.
4. Marghoob AA, Koenig K, Bittencourt FV, Kopf AW, Bart RS: Breslow thickness and Clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging. Cancer 2000;88:589-595.
5. Kaur MR, Colloby PS, Martin-Clavijo A, Marsden JR: Melanoma histopathology reporting: are we complying with the National Minimum Dataset? J Clin Pathol 2007;60:1121-1123.
6. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia 2001. Canberra, Australian Institute of Health and Welfare, Australasian Association of Cancer Registries, 2004.
7. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB: Cancer Incidence in Five Continents, vol 8. Lyon, IARC Publ No 155, 2003.
8. Calonje E: ACP best practice, No 162. The histological reporting of melanoma. Association of Clinical Pathologists. J Clin Pathol 2000;53:587-590.
9. Stata Corporation: Stata statistical software, version 9.2. College Station, Stata Corporation, 2006.
10. Maheshwari M, Read-Jones S: Audit of malignant melanoma histopathology reports. Birmingham, Royal College of Pathologists, 2006.
11. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia, an overview, 2006. Canberra, Australian Institute of Health and Welfare, Australasian Association of Cancer Registries, 2007.
12. Shaikh L, Sagebiel RW, Ferreira CM, Nosrati M, Miller JR 3rd, Kashani-Sabet M: The role of microsatellites as a prognostic factor in primary malignant melanoma. Arch Dermatol 2005;141:739-742.
13. Francken AB, Shaw HM, Thompson JF, Soong S-J, Accortt NA, Azzola MF, Scolyer RA, Milton GW, McCarthy WH, Colman MH, McGovern VJ: The prognostic importance of tumor mitotic rate confirmed in 1,317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol 2004;11:426-433.
14. Cook MG: Diagnostic discord with melanoma. J Pathol 1997;182:247-249.
15. Scolyer RA, Shaw HM, Thompson JF, Li LX, Colman MH, Lo SK, McCarthy SW, Palmer AA, Nicoll KD, Dutta B, Slobedman E, Watson GF, Stretch JR: Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. Am J Surg Pathol 2003;27:1571-1576.
16. Cook MG, Clarke TJ, Humphreys S, Fletcher A, McLaren KM, Smith NP, Stevens A, Theaker JM, Melia J: The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel. Histopathology 1996;28:497-512.
17. Lefevre M, Vergier B, Balme B, Thiebault R, Delaunay M, Thomas L, Beylot-Barry M, Machet L, De Muret A, Bioulac-Sage P, Bailly C: Relevance of vertical growth pattern in thin level II cutaneous superficial spreading melanomas. Am J Surg Pathol 2003;27:717-724.
18. Grande Sarpa H, Reinke K, Shaikh L, Leong SP, Miller JR 3rd, Sagebiel RW, Kashani-Sabet M: Prognostic significance of extent of ulceration in primary cutaneous melanoma. Am J Surg Pathol 2006;30:1396-1400.
19. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH, Morabito A: Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-3634.
20. Busam KJ: Lack of relevant information for tumor staging in pathology reports of primary cutaneous melanoma. Am J Clin Pathol 2001;115:743-746.
21. Crowson AN, Magro CM, Mihm MC: Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Mod Pathol 2006;19(suppl 2):S71-S87.
22. Scolyer RA, Thompson JF, Stretch JR, Sharma R, McCarthy SW: Pathology of melanocytic lesions: new, controversial, and clinically important issues. J Surg Oncol 2004;86:200-211.
23. Thompson JF, Scolyer RA: Cooperation between surgical oncologists and pathologists: a key element of multidisciplinary care for patients with cancer. Pathology 2004;36:496-503.
24. Liu V, Mihm MC: Pathology of malignant melanoma. Surg Clin North Am 2003;83:31-60.
25. Powsner SM, Costa J, Homer RJ: Clinicians are from Mars and pathologists are from Venus. Arch Pathol Lab Med 2000;124:1040-1046.
26. Karim RZ, van den Berg KS, Colman MH, McCarthy SW, Thompson JF, Scolyer RA: The advantage of using a synoptic pathology report format for cutaneous melanoma. Histopathology 2008;52:130-138.
27. Miller JM, Slater DN: Do histopathology reports of primary cutaneous melanoma contain enough essential information? J Clin Pathol 1996;49:202-204.